2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Poster Session

[P48] Poster Session 48 Head and Neck Cancer(ICI)

[P48-1] Efficacy and safety analysis of nivolumab at a dose of 3mg/kg vs 240mg/body in head and neck squamous cell carcinoma

Takuma Kishida1, Takuro Okada2, Kiyoaki Tukahara2, Isaku Okamoto2, Hiroki Sato2, Kunihiko Tokashiki2, Yusuke Aihara2, Tatsuya Ito2, Gai Yamashita2, Takahito Kondo1, Kouki Miura3, Yuichiro Tada3, Tatsuo Masubuchi3, Chihiro Fushimi3, Yukiomi Kushihashi3, Kenji Hanyu3, Taku Yamashita4, Takashi Matsuki4, Kaho Momiyama4, Yuuki Harada4 (1.Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University Hachioji Medical Center, 2.Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University, 3.Head and Neck Oncology Center, University of Health and Welfare Mita Hospital, 4.Department of Otorhinolaryngology, Head and Neck Surgery, Kitasato University Hospital)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password